PURPOSE: One in seven patients admitted to intensive care units (ICU) has a cancer diagnosis but evidence on their expected outcomes after admission has not been synthesised. METHODS: Systematic literature review of solid cancer adult patients admitted to ICU from 2000 onwards using EMBASE and MEDLINE electronic databases. RESULTS: There were 48 papers identified that reported survival in ICU patients with solid cancers. ICU mortality was reported in 35 studies comprising a total sample of 25,339 patients and ranging from 4.5 to 85 %. The average mortality of the distribution of reported mortality rates within ICU was 31.2 % (95 % CI 24.0-39.0 %). Hospital mortality was reported in 31 studies across a total sample of 74,061 patients. The average hospital mortality was 38.2 % (33.8-42.7 %) and ranged from 4.6 to 76.8 %. Poorer physiological score, invasive mechanical ventilation and poor functional status were associated with higher mortality. CONCLUSIONS: Several factors have been associated with poor survival in ICU cancer patients; however, primary research is still needed to describe outcomes in cancer patients with sufficient case mix and treatment details to be of prognostic value to clinicians.
PURPOSE: One in seven patients admitted to intensive care units (ICU) has a cancer diagnosis but evidence on their expected outcomes after admission has not been synthesised. METHODS: Systematic literature review of solid cancer adult patients admitted to ICU from 2000 onwards using EMBASE and MEDLINE electronic databases. RESULTS: There were 48 papers identified that reported survival in ICU patients with solid cancers. ICU mortality was reported in 35 studies comprising a total sample of 25,339 patients and ranging from 4.5 to 85 %. The average mortality of the distribution of reported mortality rates within ICU was 31.2 % (95 % CI 24.0-39.0 %). Hospital mortality was reported in 31 studies across a total sample of 74,061 patients. The average hospital mortality was 38.2 % (33.8-42.7 %) and ranged from 4.6 to 76.8 %. Poorer physiological score, invasive mechanical ventilation and poor functional status were associated with higher mortality. CONCLUSIONS: Several factors have been associated with poor survival in ICU cancerpatients; however, primary research is still needed to describe outcomes in cancerpatients with sufficient case mix and treatment details to be of prognostic value to clinicians.
Authors: Tamer Ertan; Omer Yoldas; Yusuf Alper Kilic; Mehmet Kilic; Erdal Göcmen; Mahmut Koc; Mesut Tez Journal: Am J Surg Date: 2008-04 Impact factor: 2.565
Authors: Márcio Soares; Jorge I F Salluh; Marilia S Carvalho; Michael Darmon; José R Rocco; Nelson Spector Journal: J Clin Oncol Date: 2006-08-20 Impact factor: 44.544
Authors: Monique M E M Bos; Nicolette F de Keizer; Iwan A Meynaar; Ferishta Bakhshi-Raiez; Evert de Jonge Journal: Acta Oncol Date: 2012-05-01 Impact factor: 4.089
Authors: Daniel P Park; Catherine A Welch; David A Harrison; Thomas R Palser; David A Cromwell; Fang Gao; Derek Alderson; Katherine M Rowan; Gavin D Perkins Journal: Crit Care Date: 2009 Impact factor: 9.097
Authors: Fabio Silvio Taccone; Antonio A Artigas; Charles L Sprung; Rui Moreno; Yasser Sakr; Jean-Louis Vincent Journal: Crit Care Date: 2009-02-06 Impact factor: 9.097
Authors: M P Coleman; B Rachet; L M Woods; E Mitry; M Riga; N Cooper; M J Quinn; H Brenner; J Estève Journal: Br J Cancer Date: 2004-04-05 Impact factor: 7.640
Authors: François Vincent; Sondes Yaacoubi; Abdelaziz Bouguerba; Soufia Ayed; Caroline Bornstain Journal: Support Care Cancer Date: 2017-03-18 Impact factor: 3.603
Authors: Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares Journal: Intensive Care Med Date: 2017-07-19 Impact factor: 17.440